GETINGE AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.3 SEK | +0.43% |
|
+11.05% | +3.92% |
| Apr. 24 | GETINGE : Q1 24: Investors look beyond the top-line miss |  |
| Apr. 22 | Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest | DJ |
Presentation Operator MessageOperator (Operator)Welcome to the Getinge 2023 Q1 Report with CEO...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Calendar
2024-07-18
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
232.3
SEK
Average target price
235
SEK
Spread / Average Target
+1.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.92% | 5.81B | |
| +72.58% | 12.34B | |
| -18.04% | 7.98B | |
| +6.65% | 5.04B | |
| +20.83% | 4.31B | |
| -20.27% | 4.03B | |
| -41.19% | 2.21B | |
| +0.50% | 1.99B | |
| +4.02% | 1.87B | |
| -41.64% | 1.33B |
- Stock Market
- Equities
- GETI B Stock
- News Getinge AB
- Transcript : Getinge AB, Q1 2023 Earnings Call, Apr 26, 2023
